Volpara Health (ASX: VHT), a health technology software company whose integrated breast care platform assists in the delivery of personalized patient care, is pleased to announce the acquisition of CRA Health, LLC, a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital. Volpara is paying US$18.0M to acquire all outstanding equity of CRA, with a further US$4.0M payable upon its meeting key performance targets over the next 18 months.
Read the full article: Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC. //
Source: https://www.prnewswire.com/news-releases/volpara-acquires-breast-cancer-risk-assessment-company-cra-health-llc-301219514.html